Gordon K, Thaçi D, Gooderham M, Okubo Y, Strober B, Peterson L, Deherder D, López Pinto J, Gisondi P. Bimekizumab Safety and Tolerability in Moderate to Severe Plaque Psoriasis: Pooled Analysis from Up to 4 Years of Treatment in 5 Phase 3/3b Clinical Trials. J of Skin [Internet]. 2024Jul.23 [cited 2024Jul.23];8(4):s404. Available from: https://jofskin.org/index.php/skin/article/view/2860